Literature DB >> 19214670

Role of bone marrow-derived cells in colon cancer: lessons from mouse model studies.

Makoto Mark Taketo1.   

Abstract

The role of the tumor stroma in carcinogenesis and cancer progression have been documented for a long time. However, the molecules and mechanisms involved have not been understood precisely. Recently, various mediators involved in the communication between the tumor epithelium and stroma and their roles have been revealed by utilizing new technology such as array analysis, laser capture sampling, and genetically altered mice. Moreover, accumulating evidence indicates that some cells in the tumor stroma are derived from the bone marrow (BM). While some of these BM-derived cells are well-known players in inflammation, as exemplified by macrophages, other types of BM-derived cells have been described only recently and are still poorly characterized. In this review, I focus on the latter class of BM-derived cells in colon carcinogenesis, with reference to similar cells in other types of cancer as well. Studies of these myeloid cells should help us understand the inflammation and immune response from a broader perspective as the body's reaction to pathogenic insults.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19214670     DOI: 10.1007/s00535-008-2321-3

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  48 in total

1.  A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).

Authors:  Subhra K Biswas; Lisa Gangi; Saki Paul; Tiziana Schioppa; Alessandra Saccani; Marina Sironi; Barbara Bottazzi; Andrea Doni; Bronte Vincenzo; Fabio Pasqualini; Luca Vago; Manuela Nebuloni; Alberto Mantovani; Antonio Sica
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

Review 2.  BX471: a CCR1 antagonist with anti-inflammatory activity in man.

Authors:  Richard Horuk
Journal:  Mini Rev Med Chem       Date:  2005-09       Impact factor: 3.862

3.  IL-12 rapidly alters the functional profile of tumor-associated and tumor-infiltrating macrophages in vitro and in vivo.

Authors:  Stephanie K Watkins; Nejat K Egilmez; Jill Suttles; Robert D Stout
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

4.  Localization of the gene for familial adenomatous polyposis on chromosome 5.

Authors:  W F Bodmer; C J Bailey; J Bodmer; H J Bussey; A Ellis; P Gorman; F C Lucibello; V A Murday; S H Rider; P Scambler
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

5.  Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice.

Authors:  P C Chulada; M B Thompson; J F Mahler; C M Doyle; B W Gaul; C Lee; H F Tiano; S G Morham; O Smithies; R Langenbach
Journal:  Cancer Res       Date:  2000-09-01       Impact factor: 12.701

6.  Inactivation of both APC alleles in an early stage of colon adenomas in a patient with familial adenomatous polyposis (FAP).

Authors:  S Ichii; A Horii; S Nakatsuru; J Furuyama; J Utsunomiya; Y Nakamura
Journal:  Hum Mol Genet       Date:  1992-09       Impact factor: 6.150

7.  A Robertsonian translocation suppresses a somatic recombination pathway to loss of heterozygosity.

Authors:  Kevin M Haigis; William F Dove
Journal:  Nat Genet       Date:  2002-11-25       Impact factor: 38.330

8.  Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors.

Authors:  Jeffrey B Wyckoff; Yarong Wang; Elaine Y Lin; Jiu-feng Li; Sumanta Goswami; E Richard Stanley; Jeffrey E Segall; Jeffrey W Pollard; John Condeelis
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

9.  Risk stratification of patients diagnosed with gastrointestinal stromal tumor.

Authors:  Heikki Joensuu
Journal:  Hum Pathol       Date:  2008-10       Impact factor: 3.466

10.  Genetic changes and histopathological types in colorectal tumors from patients with familial adenomatous polyposis.

Authors:  M Miyaki; M Seki; M Okamoto; A Yamanaka; Y Maeda; K Tanaka; R Kikuchi; T Iwama; T Ikeuchi; A Tonomura
Journal:  Cancer Res       Date:  1990-11-15       Impact factor: 12.701

View more
  8 in total

1.  Human Barrett's adenocarcinoma of the esophagus, associated myofibroblasts, and endothelium can arise from bone marrow-derived cells after allogeneic stem cell transplant.

Authors:  Lloyd Hutchinson; Bjorn Stenstrom; Duan Chen; Bilal Piperdi; Sara Levey; Stephen Lyle; Timothy C Wang; JeanMarie Houghton
Journal:  Stem Cells Dev       Date:  2010-10-12       Impact factor: 3.272

Review 2.  Impact of the Tumor Microenvironment for Esophageal Tumor Development-An Opportunity for Prevention?

Authors:  Martin Borgmann; Michael Quante
Journal:  Cancers (Basel)       Date:  2022-04-30       Impact factor: 6.575

Review 3.  The gastrointestinal tumor microenvironment.

Authors:  Michael Quante; Julia Varga; Timothy C Wang; Florian R Greten
Journal:  Gastroenterology       Date:  2013-04-10       Impact factor: 22.682

4.  Bone marrow-derived cells are recruited by the melanoma tumor with endothelial cells contributing to tumor vasculature.

Authors:  R Bonfim-Silva; L E B Souza; F U F Melo; V C Oliveira; D A R Magalhães; H F Oliveira; D T Covas; A M Fontes
Journal:  Clin Transl Oncol       Date:  2016-05-17       Impact factor: 3.405

Review 5.  Immune response and the tumor microenvironment: how they communicate to regulate gastric cancer.

Authors:  Keunwook Lee; Hyekyung Hwang; Ki Taek Nam
Journal:  Gut Liver       Date:  2014-03-11       Impact factor: 4.519

Review 6.  Determinants of metastatic competency in colorectal cancer.

Authors:  Daniele V F Tauriello; Alexandre Calon; Enza Lonardo; Eduard Batlle
Journal:  Mol Oncol       Date:  2017-01-03       Impact factor: 6.603

7.  Antiproliferative effects of fluoxetine on colon cancer cells and in a colonic carcinogen mouse model.

Authors:  Vinicius Kannen; Henning Hintzsche; Dalila L Zanette; Wilson A Silva; Sérgio B Garcia; Ana Maria Waaga-Gasser; Helga Stopper
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

8.  Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour-stroma interaction.

Authors:  T Nagasaki; M Hara; H Nakanishi; H Takahashi; M Sato; H Takeyama
Journal:  Br J Cancer       Date:  2013-12-17       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.